Obsidian Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 14.79 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 913.62M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory non-small cell lung cancer. It utilizes a proprietary Cytodriver technology platform designed to regulate protein function using FDA-approved small-molecule drugs and is advancing tumor-infiltrating lymphocyte (TIL) cell therapies that le...